Nasser, N.J.; Sindhu, K.K.; Nasser, L.; Shafaee, Z.; Li, J.; Resende Salgado, L.; Li, B.
Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies. Int. J. Mol. Sci. 2025, 26, 8624.
https://doi.org/10.3390/ijms26178624
AMA Style
Nasser NJ, Sindhu KK, Nasser L, Shafaee Z, Li J, Resende Salgado L, Li B.
Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies. International Journal of Molecular Sciences. 2025; 26(17):8624.
https://doi.org/10.3390/ijms26178624
Chicago/Turabian Style
Nasser, Nicola J., Kunal K. Sindhu, Loor Nasser, Zahra Shafaee, Joshua Li, Lucas Resende Salgado, and Baoqing Li.
2025. "Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies" International Journal of Molecular Sciences 26, no. 17: 8624.
https://doi.org/10.3390/ijms26178624
APA Style
Nasser, N. J., Sindhu, K. K., Nasser, L., Shafaee, Z., Li, J., Resende Salgado, L., & Li, B.
(2025). Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies. International Journal of Molecular Sciences, 26(17), 8624.
https://doi.org/10.3390/ijms26178624
